Ligand Pharmaceuticals LGND
NASDAQ LGND
$310.36 -3.74 (-1.19%)
At close: Sep 29, 2026 · 4:00 PM EDT

Ligand Pharmaceuticals (LGND) FCF Margin (2010 - 2026)

Updated

Ligand Pharmaceuticals (LGND) posted FCF Margin of 37.67% for Q2 2026, up 4.95 percentage points from 32.72% a year earlier but down 56.03 percentage points from the prior quarter.

Analysis

Ligand Pharmaceuticals (LGND) FCF Margin (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, FCF Margin at Ligand Pharmaceuticals was 45.24%, up 15.96 percentage points year-over-year; for FY2025, it was 18.24%, up 5.05 percentage points from FY2024.

  • Annual FCF Margin shows a five-year change of -12.40 percentage points (FY2020 to FY2025).
  • In prior years, Ligand Pharmaceuticals' FCF Margin was 13.19% in FY2024 (-21.88 pp), 35.07% in FY2023 (-26.04 pp), 61.11% in FY2022 (+32.12 pp) and 29.00% in FY2021 (-1.65 pp).
  • Quarterly FCF Margin has run from a low of -148.28% in Q2 2024 to a high of 129.08% in Q1 2022 over five years.
  • On a year-over-year basis, FCF Margin has increased in each of the last three quarters, with an average year-over-year change of +32.35 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for FCF Margin in the past five years was Q2 2025, with a gain of 181.00 percentage points; the weakest was Q2 2024, with a drop of 147.20 percentage points.
  • According to Business Quant data, FCF Margin for the three prior quarters was 93.70% (Q1 2026), 76.94% (Q4 2025) and 11.32% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.82%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 18.33%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 26.96%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 43.05%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 34.72%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.70%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 44.00%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 30.39%
10 Ligand Pharmaceuticals 6.26 Bn 2.72 Bn - 37.67%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 37.67%
Mar 31, 2026 93.70%
Dec 31, 2025 76.94%
Sep 30, 2025 11.32%
Jun 30, 2025 32.72%
Mar 31, 2025 -56.60%
Dec 31, 2024 66.50%
Sep 30, 2024 70.50%
Jun 30, 2024 -148.28%
Mar 31, 2024 60.13%
Dec 31, 2023 27.22%
Sep 30, 2023 21.78%
Jun 30, 2023 -1.08%
Mar 31, 2023 71.70%
Dec 31, 2022 101.90%
Sep 30, 2022 27.29%
Jun 30, 2022 10.55%
Mar 31, 2022 129.08%
Dec 31, 2021 45.12%
Sep 30, 2021 30.58%
API Access

Ligand Pharmaceuticals FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=LGND&period=max&api_key=YOUR_API_KEY